Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

FDG PET/CT scans can change cancer treatment plans for dogs.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Wnt signaling is crucial for skin and hair development and its disruption can cause skin tumors.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Early onset hair loss linked to genetics and androgen levels.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.